Scilex Holding Co (NASDAQ: SCLX) reported Q2 2024 earnings per share (EPS) of -$0.31, up 63.16% year over year. Total Scilex Holding Co earnings for the quarter were -$37.58 million. In the same quarter last year, Scilex Holding Co's earnings per share (EPS) was -$0.19.
As of Q3 2024, Scilex Holding Co's earnings has grown year over year. Scilex Holding Co's earnings in the past year totalled -$118.89 million.
What was SCLX's revenue last quarter?
Scilex Holding Co (NASDAQ: SCLX) reported Q2 2024 revenue of $16.37 million up 30.11% year over year. In the same quarter last year, Scilex Holding Co's revenue was $12.58 million.
What was SCLX's revenue growth in the past year?
As of Q3 2024, Scilex Holding Co's revenue has grown 9.41% year over year. This is 1.57 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 10.99%. Scilex Holding Co's revenue in the past year totalled $50.83 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.